Dr Angela M. Minassian

2022 Paul T. Heath, Eva P. Galiza, David Neil Baxter, Marta Boffito, Duncan Browne, Fiona Burns, David R. Chadwick, Rebecca Clark, Catherine A. Cosgrove, James Galloway, Anna L. Goodman, Amardeep Heer, Andrew Higham, Shalini Iyengar, Christopher Jeanes and 30 other authors

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

Upload

Jo Salkeld, Yrene Themistocleous, Jordan R. Barrett, Celia H. Mitton, Thomas A. Rawlinson, Barrett Jr, Ruth O. Payne, Mimi M. Hou, Mitton Ch, Nick J. Edwards, Rawlinson Ta, Carolyn M. Nielsen, Baktash Khozoee, Diana Muñoz Sandoval, Florian A. Bach and 22 other authors

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics

Download from doi.org

Xinxue Liu, Alasdair P. S. Munro, Shuo Feng, Leila Janani, Parvinder K. Aley, Gavin Babbage, David Baxter, Marcin Bula, Katrina Cathie

, Krishna Chatterjee, Wanwisa Dejnirattisai, Kate Dodd, Yvanne Enever, Ehsaan Qureshi, Anna L. Goodman and 43 other authors

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.

Upload

Alasdair P. S. Munro, Shuo Feng, Leila Janani, Victoria Cornelius, Parvinder K. Aley, Gavin Babbage, David Baxter, Marcin Bula, Katrina Cathie, Krishna Chatterjee, Kate Dodd, Yvanne Enever, Ehsaan Qureshi, Anna L. Goodman, Christopher A. Green and 294 other authors

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Upload

Seth Toback, Eva Galiza, Catherine Cosgrove, James Galloway, Anna L. Goodman, Pauline A. Swift, Sankarasubramanian Rajaram, Alison Graves-Jones, Jonathan Edelman, Fiona Burns, Angela M. Minassian

, Iksung Cho, Lakshmi Kumar, Joyce S. Plested, E. Joy Rivers and 297 other authors

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

Upload

Immunogenicity and Reactogenicity of BNT162b2 and mRNA1273 COVID-19 Vaccines Given as Fourth Dose Boosters in the COV-BOOST Randomised Trial Following Two Doses of ChAdOx1 nCov-19 or BNT162b2 and a Third Dose of BNT162b2

Upload

2021 Angela M. Minassian

, Yrene Themistocleous, Sarah E. Silk

, Jordan R. Barrett

, Alison Kemp, Doris Quinkert

, Carolyn M. Nielsen

, Nick J. Edwards

, Thomas A. Rawlinson, Fernando Ramos Lopez, Wanlapa Roobsoong

, Katherine J. D. Ellis, Jee-Sun Cho, Eerik Aunin

, Thomas D. Otto

and 30 other authors

Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly

Download from doi.org

Alasdair P. S. Munro, Leila Janani, Victoria Cornelius, Parvinder K. Aley, Gavin Babbage, David Baxter, Marcin Bula, Katrina Cathie, Krishna Chatterjee, Kate Dodd, Yvanne Enever, Karishma Gokani, Anna L. Goodman, Christopher A. Green, Linda Harndahl and 293 other authors

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Upload

Kushalinii Hillson, Sue Costa Clemens, Shabir A. Madhi, Merryn Voysey, Andrew J. Pollard, Angela M. Minassian

Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination

Upload

Amy Flaxman, Natalie G. Marchevsky, Daniel Jenkin, Jeremy Aboagye, Parvinder K. Aley, Brian Angus, Sandra Belij-Rammerstorfer, Sagida Bibi, Mustapha Bittaye, Federica Cappuccini, Paola Cicconi, Elizabeth A. Clutterbuck, Sophie Davies, Wanwisa Dejnirattisai, Christina Dold

and 172 other authors

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Upload

Hans de Graaf, Ruth O. Payne, Iona Taylor, Kazutoyo Miura, Carol A. Long, Sean C. Elias, Marija Zaric, Angela M. Minassian

, Sarah E. Silk, Lee Li, Ian D. Poulton, Megan Baker, Simon J. Draper, Diane Gbesemete, Nathan J. Brendish and 13 other authors

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Dr Angela M. Minassian